New trends in patient management: risk-based therapy for febrile patients with neutropenia

Clicks: 428
ID: 111956
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Standard management of febrile neutropenia includes the prompt administration of empirical, broad-spectrum, parenteral antibiotic therapy. This is generally done in a hospital-based setting. Although effective (overall survival of >90%), such therapy leads to prolonged hospitalization, excessive …
Reference Key
kv1999clinicalnew Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rolston KV;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 1999
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10530438
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine prognosis female male anti-bacterial agents / administration & dosage* risk assessment bacterial infections / complications bacterial infections / drug therapy* fever / prevention & control* neutropenia / prevention & control* patient selection oral pmid:10530438 doi:10.1086/598624 k v rolston ambulatory care / trends* fever / complications neoplasms / complications neutropenia / complications

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.